amifostine anhydrous has been researched along with Canine Diseases in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seventy-three dogs with soft tissue sarcomas were randomized to 2 dose response assays to receive irradiation alone or with the radioprotector WR-2721." | 2.66 | Influence of WR 2721 on radiation response of canine soft tissue sarcomas. ( Dewhirst, MW; Gillette, EL; McChesney, SL; Withrow, SJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McChesney, SL | 1 |
| Gillette, EL | 1 |
| Dewhirst, MW | 1 |
| Withrow, SJ | 1 |
1 trial available for amifostine anhydrous and Canine Diseases
| Article | Year |
|---|---|
Influence of WR 2721 on radiation response of canine soft tissue sarcomas.
Topics: Amifostine; Animals; Clinical Trials as Topic; Combined Modality Therapy; Dog Diseases; Dogs; Organo | 1986 |